Perrigo Company said that search warrants were executed at its corporate offices linked to an ongoing investigation by the US Department of Justice Antitrust Division.
The investigation is related to drug pricing in the pharmaceutical industry, it said in a statement late on Tuesday.
“As has been previously disclosed by a number of companies, the Antitrust Division has been looking at industry-wide pricing practices,” Perrigo said in a statement. “The company is taking this investigation seriously and is cooperating with the appropriate authorities.”
The development offers a window into the Justice Department’s ongoing investigation into alleged collusion among drug companies to set prices artificially high.
Full Content: USA Today
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Former Novartis Executive Sentenced to Probation for Role in Generic Drug Price-Fixing Scheme
May 16, 2024 by
CPI
NCAA Faces Bankruptcy Threat from Antitrust Lawsuits
May 16, 2024 by
CPI
K&L Gates Expands Antitrust Practice with New Partners
May 15, 2024 by
CPI
Polish Regulators Probe PS Store and Steam for Antitrust Violations
May 15, 2024 by
CPI
French Regulator Meat-Cutting Sector Case Following Antitrust Review
May 15, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI